| Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma … V Vilgrain, H Pereira, E Assenat, B Guiu, AD Ilonca, GP Pageaux, A Sibert, ... The Lancet Oncology 18 (12), 1624-1636, 2017 | 769 | 2017 |
| Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised … E Garin, L Tselikas, B Guiu, J Chalaye, J Edeline, T de Baere, E Assenat, ... The lancet Gastroenterology & hepatology 6 (1), 17-29, 2021 | 360 | 2021 |
| Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma J Chalaye, CE Costentin, A Luciani, G Amaddeo, N Ganne-Carrié, ... Journal of hepatology 69 (2), 336-344, 2018 | 66 | 2018 |
| [18F]-NaF PET/CT imaging in cardiac amyloidosis A Van Der Gucht, A Galat, J Rosso, A Guellich, J Garot, D Bodez, ... Journal of nuclear cardiology 23, 846-849, 2016 | 54 | 2016 |
| 18F-FDG PET/CT predicts microvascular invasion and early recurrence after liver resection for hepatocellular carcinoma: a prospective observational study C Lim, C Salloum, J Chalaye, E Lahat, CE Costentin, M Osseis, E Itti, ... HPB 21 (6), 739-747, 2019 | 41 | 2019 |
| Major impact of personalized dosimetry using 90Y loaded glass microspheres SIRT in HCC: Final overall survival analysis of a multicenter randomized phase II study (DOSISPHERE-01). E Garin, L Tzelikas, B Guiu, J Chalaye, J Edeline, T De Baere, V Tacher, ... Journal of Clinical Oncology 38 (4_suppl), 516-516, 2020 | 33 | 2020 |
| Hepatocellular carcinomas with mutational activation of beta-catenin require choline and can be detected by positron emission tomography A Gougelet, C Sartor, N Senni, J Calderaro, L Fartoux, M Lequoy, ... Gastroenterology 157 (3), 807-822, 2019 | 28 | 2019 |
| Neuropsychological correlates of brain perfusion SPECT in patients with macrophagic myofasciitis A Van Der Gucht, M Aoun Sebaiti, E Itti, J Aouizerate, E Evangelista, ... PLoS One 10 (6), e0128353, 2015 | 28 | 2015 |
| Clinical impact of contrast-enhanced computed tomography combined with low-dose 18F-fluorodeoxyglucose positron emission tomography/computed … J Chalaye, A Luciani, C Enache, P Beaussart, C Lhermite, E Evangelista, ... Leukemia & Lymphoma 55 (12), 2887-2892, 2014 | 27 | 2014 |
| Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and 18F-FDG PET/CT in patients on waiting-list for liver transplantation S Boussouar, E Itti, SJ Lin, T Decaens, E Evangelista, M Chiaradia, ... Cancer Imaging 16, 1-9, 2016 | 24 | 2016 |
| Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma … S Mulé, J Chalaye, F Legou, A Tenenhaus, J Calderaro, ... European Radiology 30, 5348-5357, 2020 | 20 | 2020 |
| Prediction of overall survival in patients with hepatocellular carcinoma treated with Y-90 radioembolization by imaging response criteria M Ghosn, H Derbel, R Kharrat, N Oubaya, S Mulé, J Chalaye, H Regnault, ... Diagnostic and Interventional Imaging 102 (1), 35-44, 2021 | 19 | 2021 |
| Brain 18F-FDG PET metabolic abnormalities in patients with long-lasting macrophagic myofascitis A Van Der Gucht, MA Sebaiti, E Guedj, J Aouizerate, S Yara, RK Gherardi, ... Journal of Nuclear Medicine 58 (3), 492-498, 2017 | 16 | 2017 |
| Health-related quality of life in locally advanced hepatocellular carcinoma treated by either radioembolisation or sorafenib (SARAH trial) H Pereira, M Bouattour, MD Burgio, E Assenat, J Grégory, JP Bronowicki, ... European Journal of Cancer 154, 46-56, 2021 | 15 | 2021 |
| Chest PET/MRI in Solid Cancers: Comparing the Diagnostic Performance of a Free‐Breathing 3D‐T1‐GRE Stack‐of‐Stars Volume Interpolated Breath‐Hold Examination (StarVIBE … M Vermersch, B Emsen, A Monnet, J Chalaye, A Galletto Pregliasco, ... Journal of Magnetic Resonance Imaging 55 (6), 1683-1693, 2022 | 11 | 2022 |
| Clinical impact of dual-tracer FDOPA and FDG PET/CT for the evaluation of patients with parkinsonian syndromes B Emsen, G Villafane, JP David, E Evangelista, J Chalaye, L Lerman, ... Medicine 99 (45), e23060, 2020 | 10 | 2020 |
| Impact of the 18F-FDG-PET/MRI on Metastatic Staging in Patients with Hepatocellular Carcinoma: Initial Results from 104 Patients M Vermersch, S Mulé, J Chalaye, A Galletto Pregliasco, B Emsen, ... Journal of Clinical Medicine 10 (17), 4017, 2021 | 7 | 2021 |
| Cost-utility analysis of transarterial radioembolization with Yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma K Zarca, M Mimouni, H Pereira, G Chatellier, V Vilgrain, I Durand-Zaleski, ... Clinical Therapeutics 43 (7), 1201-1212, 2021 | 6 | 2021 |
| Utility of Early Posttreatment PET/CT Evaluation Using FDG or 18F-FCH to Predict Response to 90Y Radioembolization in Patients With Hepatocellular Carcinoma E Reizine, J Chalaye, S Mule, H Regnault, C Perrin, J Calderaro, ... American Journal of Roentgenology 218 (2), 359-369, 2022 | 5 | 2022 |
| Brain 18F-FDG, 18F-Florbetaben PET/CT, 123I-FP-CIT SPECT and Cardiac 123I-MIBG Imaging for Diagnosis of a "Cerebral Type" of Lewy Body Disease A Van Der Gucht, L Cleret de Langavant, O Bélissant, C Rabu, ... Nuclear medicine and molecular imaging 50, 258-260, 2016 | 5 | 2016 |
